pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,172 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×type: earnings×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05279040: Trikafta Exercise Study in Cystic Fibrosis

    Sponsor: University of British Columbia. Phase: . Conditions: Cystic Fibrosis, Lung Diseases

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03016689: The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial Development

    Sponsor: University of Minnesota. Phase: . Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05440617: Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

    Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Acute Ovarian Failure, Infertility, Early Menopause And Infertility In Females After Treatment For Childhood Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06680817: A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

    Sponsor: Hoffmann-La Roche. Phase: . Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05755217: Renal Ultrasound Response After Chocolate Consumption

    Sponsor: Gregoire Wuerzner; MD. Phase: NA. Conditions: Chocolate Consumption

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04669912: COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management

    Sponsor: Centre Hospitalier Sud Francilien. Phase: . Conditions: Type 1 Diabetes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05405712: Mobile Peer Support for OUD Recovery

    Sponsor: Brown University. Phase: NA. Conditions: Opioid Use Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07375719: Nuclear Abnormalities in Gingival Epithelial Cells in Relation to Periodontal Disease

    Sponsor: Çankırı Karatekin University. Phase: . Conditions: Diabetes (DM), Periodontitis, Periodontitis (Stage 3), Micronuclei Count

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05033119: PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics

    Sponsor: Ulla Schierup Nielsen. Phase: . Conditions: Hyperprolactinemia, Puberty Disorders, Metabolic Syndrome, Growth Disorders, Antipsychotics and Neuroleptics Toxicity

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07367919: The Effect of a Digital Literacy Program on Problematic Internet Use, Emotion Regulation, and Loneliness in Adolescents: A Randomized Controlled Trial

    Sponsor: Ataturk University. Phase: NA. Conditions: Healthy Adolescents

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05238519: Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

    Sponsor: Essentia Health. Phase: PHASE3. Conditions: Familial Hypercholesterolemia, Cholesterol, Elevated, Genetic Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07597928: A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults

    Sponsor: Pfizer. Phase: PHASE1. Conditions: Healthy Adults, Healthy

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT03974828: Telemedicine Notifications With Machine Learning for Postoperative Care

    Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Surgery--Complications, Perioperative/Postoperative Complications, Acute Kidney Injury, Hospital Mortality

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07027267: Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery

    Sponsor: Spirair, Inc. Phase: NA. Conditions: Sinus Endoscopic Surgery, Turbinate

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06998407: ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

    Sponsor: Avenzo Therapeutics, Inc.. Phase: PHASE1. Conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02177292: High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)

    Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06930092: RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy

    Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Ischemic Cardiomyopathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04898634: A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

    Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Prostatic Neoplasms

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07256444: Feasibility Study of a Transition Pathway at Discharge From Full Hospitalization in Oncology

    Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07514234: Optimal Allogeneic PRP Concentration for Oocyte In Vitro Maturation in Women With PCOS

    Sponsor: Gadjah Mada University. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07454109: The Effect of a Stress Coping Training Program for University Students

    Sponsor: Hacettepe University. Phase: NA. Conditions: Stress

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07585799: Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction

    Sponsor: Óscar Cano Pérez. Phase: NA. Conditions: Bradycardia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07580963: Stent Related Symptoms Defined by Ureteral Stent Symptom Questionnaire in Patients With Image-Informed Ureteral Stent Lengths

    Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Ureteral Stent-Related Symptom

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07527793: Monitoring Changes in Blood Circulating Metabolites Using Minimally Invasive Techniques

    Sponsor: Örebro University, Sweden. Phase: NA. Conditions: Healthy Participants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06275893: IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy

    Sponsor: Implicit Bioscience. Phase: PHASE1. Conditions: Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Left Ventricular Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy 1, Arrhythmogenic Cardiomyopathy, ACM, ARVC, PKP2

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06670521: Corticosteroids for Post-Extubation Dysphagia

    Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Dysphagia, Laryngeal Edema

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06716021: ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

    Sponsor: Milestone Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Atrial Fibrillation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07333521: Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Isolated Non-acquired Growth Hormone Deficiency

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07469514: Coaching, Learning, Empowerment in Cerebral Palsy - a 6-Week Integrated PT/OT Caregiver "Primer" Bootcamp for Infants Diagnosed With or at High Risk for Cerebral Palsy

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Cerebral Palsy, Cerebral Palsy (CP), Cerebral Palsy Infantile, Infant

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04747314: Treating Negative Affect in Low Back Pain Patients

    Sponsor: Ajay Wasan, MD, Msc. Phase: PHASE2. Conditions: Chronic Low Back Pain, Negative Affectivity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05125016: A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Metastatic Castration-resistant Prostate Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06157216: Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer

    Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Stage II-III Gastric Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04276116: Effectiveness of the Evaluation and Communication of "Pulmonary Age" as Help for Smoking Cessation

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Smoking Cessation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06724484: Post-operative Anxiety and Depression Among Older Adults Who Undergo Surgery for Fragility Fractures

    Sponsor: University of Southampton. Phase: . Conditions: Fractures in the Elderly

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05858684: Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients

    Sponsor: RenJi Hospital. Phase: EARLY_PHASE1. Conditions: CAR-T Cell Therapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06639984: Psyllium in Pediatric IBS

    Sponsor: Dr Bruno Chumpitazi, M.D.. Phase: PHASE2. Conditions: Irritable Bowel Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07483047: Prediction Model for Postoperative Cognitive Dysfunction in Elderly Cardiac Patients: A Special Disease Cohort Study

    Sponsor: Shanghai Geriatric Medical Center. Phase: . Conditions: Postoperative Cognitive Dysfunction (POCD), Cardiac Diseases Requiring Surgery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03065452: Sagittal Imbalance and Lumbar Stenosis Surgery: Decompression Without Implant

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Lumbar Stenosis, Familial

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07401849: Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care

    Sponsor: Imperial College London. Phase: . Conditions: Alzheimer Disease, Biomarkers / Blood, Biomarker in Early Diagnosis, Mild Cognitive Impairment (MCI)

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07564947: Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

    Sponsor: University of Agriculture, Peshawar. Phase: NA. Conditions: MAFLD, Fatty Liver, Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD, Fatty Liver, Nonalcoholic, Fatty Liver Disease, Oxidative Stress, Inflammation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00983658: A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma

    Sponsor: Genentech, Inc.. Phase: PHASE2. Conditions: Asthma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06607458: Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

    Sponsor: Delcath Systems Inc.. Phase: PHASE2. Conditions: Refractory Metastatic Colorectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06839248: Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

    Sponsor: St Vincent's Hospital Melbourne. Phase: NA. Conditions: Residual Gastric Contents, Pulmonary Aspiration of Gastric Contents

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07478848: Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

    Sponsor: Abramson Cancer Center at Penn Medicine. Phase: PHASE1. Conditions: Large B Cell Lymphoma, Non Hodgkin Lymphoma (NHL), Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07242248: A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

    Sponsor: Janssen-Cilag Ltd.. Phase: . Conditions: Inflammatory Bowel Disease, Colitis, Ulcerative, Crohn's Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07180355: A Study of SGT-212 Gene Therapy in Friedreich's Ataxia

    Sponsor: Solid Biosciences Inc.. Phase: PHASE1. Conditions: Friedreich's Ataxia (FA)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06747455: BCG for Therapeutic Use Phase Ⅲ Clinical Trial

    Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.. Phase: PHASE3. Conditions: BCG

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07634055: Assessment of Motor Reserve in the Preclinical Stages of Dementia

    Sponsor: Istituto per la Ricerca e l'Innovazione Biomedica. Phase: . Conditions: Mild Cognitive Impairment (MCI)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07405957: Effects of Two Different Lion's Mane Extracts (Lions Mane Fruiting Body & Lions Mane Fruiting Body With Mycellium) on Cognitive Performance, Subjective Affect, Serum Biomarkers, and Gut Microbiota in Healthy Adults

    Sponsor: Applied Food Sciences Inc.. Phase: NA. Conditions: Healthy Adult Females, Healthy Adult Male

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06771401: Identification of Biomarkers in Cervical Mucus

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: NA. Conditions: Cervical Mucus Dysfunction, Infertility, Female

    full page →ctgov ↗
    ← prev
    page 60 of 104
    next →